ProMIS Neurosciences Stock

ProMIS Neurosciences Dividend 2024

ProMIS Neurosciences Dividend

0 CAD

ProMIS Neurosciences Dividend yield

Ticker

PMN.TO

ISIN

CA74346M1095

WKN

A14WN0

How much dividend does ProMIS Neurosciences 2024 pay?

According to the latest status from November 2024, ProMIS Neurosciences paid a total of 0 CAD per share in dividends within the last 12 months. With the current ProMIS Neurosciences price of 6 CAD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical ProMIS Neurosciences Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the ProMIS Neurosciences Dividend Safe?

ProMIS Neurosciences has been increasing the dividend for 0 years.

Over the past 10 years, ProMIS Neurosciences has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding ProMIS Neurosciences's Dividend Distributions

ProMIS Neurosciences’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining ProMIS Neurosciences's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

ProMIS Neurosciences's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in ProMIS Neurosciences’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

ProMIS Neurosciences Aktienanalyse

What does ProMIS Neurosciences do?

ProMIS Neurosciences Inc is a biopharmaceutical company based in Canada that specializes in the discovery and development of novel therapeutics for neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS. The company was founded in 2004 and has been listed on the Toronto Stock Exchange since 2015. The goal of ProMIS is to develop highly specific therapeutics that specifically target the cellular causes of neurodegenerative diseases and can therefore stop or even reverse the progression of the disease. The company utilizes its proprietary platform technology to identify the unique epitopes on the pathological proteins that are specific to neurodegenerative diseases. ProMIS' business model is based on partnerships with large pharmaceutical companies that are searching for new therapeutics for neurodegenerative diseases. ProMIS works closely with these partners to develop customized therapeutics tailored to each partner's specific needs. The company licenses its technology and products to its partners and receives license and milestone payments when certain development or sales goals are achieved. ProMIS has different divisions to focus on various neurodegenerative diseases, with a focus on Alzheimer's, Parkinson's, and ALS. ProMIS has a comprehensive research and development infrastructure that focuses on the identification, characterization, and optimization of therapeutic antibodies and biomarkers. In terms of products, ProMIS has developed various antibodies that specifically target pathological proteins such as Aß and Tau in Alzheimer's and alpha-synuclein in Parkinson's. These antibodies can selectively recognize and bind to these pathological proteins, allowing them to be broken down and removed from the body. ProMIS works closely with its partners to test these antibodies in clinical trials and eventually bring them to market. In addition to its antibody products, ProMIS has also developed neuromethods that allow researchers to characterize and quantify the functions of proteins in brain cells and in vivo. These methods can be used to test and optimize the effects of antibodies and other therapeutics, making them an important part of ProMIS' development infrastructure. Overall, ProMIS Neurosciences Inc is an innovative biopharmaceutical company that focuses on the development of highly specific therapeutics for neurodegenerative diseases. The company has a comprehensive infrastructure and technology platform that allows it to develop customized products for its partners. With its antibodies and neuromethods, ProMIS has the potential to make a breakthrough in the treatment of neurodegenerative diseases and improve the lives of millions of patients. ProMIS Neurosciences is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The ProMIS Neurosciences stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about ProMIS Neurosciences stock

How much dividend does ProMIS Neurosciences pay?

Over the past 12 months, ProMIS Neurosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ProMIS Neurosciences is expected to pay a dividend of 0 CAD.

What is the dividend yield of ProMIS Neurosciences?

The current dividend yield of ProMIS Neurosciences is .

When does ProMIS Neurosciences pay dividends?

ProMIS Neurosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ProMIS Neurosciences?

ProMIS Neurosciences paid dividends every year for the past 0 years.

What is the dividend of ProMIS Neurosciences?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ProMIS Neurosciences located?

ProMIS Neurosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von ProMIS Neurosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ProMIS Neurosciences from 11/4/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did ProMIS Neurosciences pay the last dividend?

The last dividend was paid out on 11/4/2024.

What was the dividend of ProMIS Neurosciences in the year 2023?

In the year 2023, ProMIS Neurosciences distributed 0 CAD as dividends.

In which currency does ProMIS Neurosciences pay out the dividend?

The dividends of ProMIS Neurosciences are distributed in CAD.

Andere Kennzahlen von ProMIS Neurosciences

Our stock analysis for ProMIS Neurosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ProMIS Neurosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.